P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

September 2011

Features

Q&A

A Conversation With Ruth M. Parker, MD

Are We Finally Getting Somewhere With Health Literacy in the U.S.?

One-third of patients cannot read or understand their prescription labels and related medication materials. Dr. Parker, a clinician educator, discusses her collaborations with other professionals in the effort to tackle the widespread problem of limited health literacy.
Sonja Sherritze, Editor, P&T

Health Literacy in the Pharmacy

Practical Strategies to Improve Communication With Patients

Poor health literacy is a major cause of the inability of patients to take their medications properly. This article discusses strategies that can be implemented at both the individual and the system levels.
Adam Carlisle, MD; Kara L. Jacobson, MPH; Lorenzo Di Francesco, MD; and Ruth M. Parker, MD

Role of Maintenance Rituximab (Rituxan) Therapy in the Treatment of Follicular Lymphoma

Maintenance treatment with rituximab has been found to improve outcomes in patients with both untreated and relapsed follicular lymphoma. However, more studies are needed to determine the optimal timing, schedule, and duration of therapy.
Nathan H. Fowler, MD

Meeting Highlights

15th International Congress of Parkinson’s Disease and Movement Disorders and Inaugural Melanoma and Cutaneous Malignancy Meeting

At the movement disorders meeting, therapies included incobotulinumtoxinA (Xeomin) for blepharospasm and cervical dystonia, a rotigotine patch (Neupro) for restless legs syndrome, and a carbidopa/levodopa capsule (IPX066) for Parkinson’s disease. Topics covered at the melanoma meeting included interferon and three novel intralesional therapies (Allovectin, OncoVex, and Rose Bengal).

Departments

Medication Errors

Intimidation by Superiors Affects the Safety of Medical Orders

Staff members often feel too intimidated to question superiors about potential prescribing errors.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

New Proposed HIPAA Disclosures Vex Health Care Players

Who Is Asking for the Information Anyway?

New HIPAA, HITECH provisions will make things more complicated for pharmacists and their software systems.
Stephen Barlas

Pharmaceutical Approval Update

Brilinta for ACS, Xarelto for DVT, and Arcapta Neohaler for COPD
Marvin M. Goldenberg, PhD, RPh, MS

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Drug Forecast

Vorapaxar: Targeting a Novel Antiplatelet Pathway

Vorapaxar, an investigational antiplatelet agent
Younos Abdulsattar, PharmD, BCPS; Theologia Ternas, PharmD; and Danielle Garcia, PharmD